
Is WST (West Pharmaceutical Services, Inc.) Halal or Haram?
West Pharmaceutical Services comfortably passes all AAOIFI Shariah screens, making it a compliant investment for Muslim portfolios. The company maintains an exceptionally low Debt to Market Cap ratio of just 2.0%, well below the 33% limit. Furthermore, its interest income and cash reserves are negligible at 0.58% and 3.8% respectively, indicating clean financial practices.
Price Chart (5D)
WST — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 294.27 | 301.09 | 294.27 | 300.68 | 652K | +2.18% |
| 2026-04-30 | 295.58 | 300.72 | 293.48 | 297.59 | 1.1M | +0.68% |
| 2026-04-29 | 296.25 | 299.51 | 292.68 | 295.36 | 796K | -0.30% |
| 2026-04-28 | 301.91 | 302.55 | 290.41 | 292.13 | 1.2M | -3.24% |
| 2026-04-27 | 304.40 | 309.99 | 300.31 | 302.20 | 1.1M | -0.72% |
| 2026-04-24 | 316.00 | 316.00 | 301.46 | 306.16 | 1.3M | -3.11% |
| 2026-04-23 | 308.01 | 320.33 | 303.20 | 309.70 | 2.7M | +0.55% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for WST
Business Activity
Permissible
WST's business activity passes Shariah screening as manufacturing containment and delivery systems for injectable drugs, such as stoppers and syringe components, is entirely permissible in Islamic finance.
Debt / Market Cap
2.02%
Interest Income
0.58%
Cash & Securities
3.83%
About West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. (WST) is a key player in the healthcare sector, specializing in the design and manufacture of containment and delivery systems for injectable drugs. Operating globally, the company produces essential medical supplies such as stoppers, seals, and advanced syringe components that ensure the safe administration of healthcare products.
For Muslim investors, WST represents a strong Halal investment opportunity as it successfully passes all four AAOIFI Shariah screens. The company's core operations in medical instruments are fully permissible, and its financial structure strictly adheres to Islamic guidelines, meaning investors can confidently add this stock to their halal portfolios.
From a financial perspective, WST boasts an incredibly clean balance sheet that aligns perfectly with Islamic finance principles. The company's Debt to Market Cap ratio sits at a mere 2.0%, while interest-generating cash and securities account for only 3.8% of its market cap, both remaining far below the strict 33% AAOIFI thresholds.
Because West Pharmaceutical Services operates in a universally permissible industry with virtually no reliance on interest-bearing debt, there is no significant scholarly debate regarding its compliance. Halal investors should simply continue to monitor its quarterly earnings to ensure debt and interest income ratios remain comfortably within permissible limits.
WST Key Financial Statistics
Revenue
$3.07B
Net Income
$493.7M
EPS (Diluted)
$6.80
Stock Price
292.13
Beta
1.15
52-Week Range
202.79-322.34
Total Debt
$416.7M
Total Equity
$3.18B
Current Ratio
3.02
WST Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+6.3%
Prior year: $2.89B
Net Cash
$374.6M
Cash: $791.3M — Debt: $416.7M
R&D Spending
$74.3M
% of Revenue
2.4%
Frequently Asked Questions About WST
Is WST (West Pharmaceutical Services, Inc.) stock halal to invest in?▾
What does West Pharmaceutical Services, Inc. do?▾
What screening criteria were used for WST?▾
Does WST require income purification?▾
When was WST last screened?▾
Disclaimer
This shariah compliance assessment for WST (West Pharmaceutical Services, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.